ConvaTec Executes Share Buyback as Part of $300 Million Program

An announcement from ConvaTec ( (GB:CTEC) ) is now available.

ConvaTec Group PLC has executed a share buyback, purchasing 1,235,062 ordinary shares as part of its $300 million buyback program announced earlier in August 2025. This move is part of the company’s strategy to manage its capital structure and return value to shareholders, potentially enhancing its market position and signaling confidence in its financial health.

The most recent analyst rating on (GB:CTEC) stock is a Buy with a £315.00 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.

Spark’s Take on GB:CTEC Stock

According to Spark, TipRanks’ AI Analyst, GB:CTEC is a Neutral.

ConvaTec’s strong financial performance and strategic positioning are tempered by bearish technical indicators and a high valuation. Regulatory challenges may pose risks, but the company’s innovation pipeline and operational strength support a moderately positive outlook.

To see Spark’s full report on GB:CTEC stock, click here.

More about ConvaTec

ConvaTec Group PLC operates in the medical products and technologies industry, focusing on providing solutions for advanced wound care, ostomy care, continence and critical care, and infusion care. The company is committed to improving the lives of patients and healthcare providers through innovative products and services.

Average Trading Volume: 7,998,291

Technical Sentiment Signal: Buy

Current Market Cap: £4.96B

See more data about CTEC stock on TipRanks’ Stock Analysis page.